HBM Healthcare Investments AG

Equities

HBMN

CH0012627250

Investment Management & Fund Operators

Market Closed - Swiss Exchange Other stock markets 11:30:57 2025-12-05 am EST			5-day change	1st Jan Change
206.00 ^CHF	+0.24%		-0.96%	+17.05%

Nov. 17	DKSH Reportedly to Weigh Bid for Pharma Distributor Swixx Biopharma	CI
Nov. 17	DKSH Emerges as Contender for Swiss Drug Service Company Swixx BioPharma	MT

Tranche Update on HBM Healthcare Investments AG's Equity Buyback Plan announced on June 28, 2022.

Published on 06/30/2025 at 12:00 am EDT

S&P Capital IQ

HBM Healthcare Investments AG

+0.24%

From April 1, 2024 to June 27, 2025, the company has repurchased 163,250 shares. With this, the company has completed the repurchase of 252,610 share for CHF 46.3 million under the buyback announced on June 28, 2022.

Latest news about HBM Healthcare Investments AG

Nov. 17	DKSH Reportedly to Weigh Bid for Pharma Distributor Swixx Biopharma	CI
Nov. 17	DKSH Emerges as Contender for Swiss Drug Service Company Swixx BioPharma	MT
Oct. 24	HBM Healthcare Investments AG Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
Oct. 24	HBM Healthcare Investments Posts Higher Fiscal H1 Net Result	MT
Oct. 22	EQT Co-Leads $183 Million Funding Round of U.S. Biotech Electra Therapeutics	DJ
Oct. 22	EQT Unit Invests in US Biotechnology Company Electra Therapeutics	MT
Oct. 01	HBM Healthcare Investments AG Provides Earnings Guidance for the First Half of the Current Financial Year 2025/2026	CI
Sep. 10	HBM Healthcare Portfolio Company Lands Distribution Deal with H. Lundbeck	MT
Sep. 10	Swixx BioPharma and H. Lundbeck A/S Sign Multi-Regional CNS Partnership	CI
Jul. 18	Swiss Stocks End Week Upbeat; Schindler Shares Down	MT
Jul. 18	HBM Healthcare Investments Swings to Q1 Loss	MT
Jul. 18	Swiss stocks - Factors to watch on July 18	RE
Jul. 18	HBM Healthcare Investments says qtrly NAV per share declined by 8.4 percent	RE
Jul. 14	HBM Healthcare Investments AG Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
Jul. 02	HBM Healthcare Investments to Repurchase 10% of Share Capital in New Program	MT
Jun. 30	HBM Healthcare Investments Wraps Up Share Buyback Program	MT
Jun. 30	Tranche Update on HBM Healthcare Investments AG's Equity Buyback Plan announced on June 28, 2022.	CI
Jun. 27	HBM Healthcare Investments AG's Equity Buyback announced on June 28, 2022, has closed with 252,610 share for CHF 46.3 million.	CI
May. 15	HBM Healthcare Investments Reports Return to Profit for FY25; Result from Investments Rises	MT
May. 14	HBM Healthcare Investments AG announces Annual dividend, payable on July 04, 2025	CI
May. 13	HBM Healthcare Investments AG Reports Earnings Results for the Full Year Ended March 31, 2025	CI
Apr. 02	HBM Healthcare Investments Flags Return to Net Profit for FY25	MT
Apr. 01	HBM Healthcare Investments AG Provides Earnings Guidance for the Financial Year 2024/2025	CI
Mar. 20	Sanofi Expands Immunology Push with Up to $1.9 Billion Bispecific Deal With Dren Bio	MT
Mar. 20	Sanofi to Buy Dren Bio's Myeloid Cell Engager DR-0201	MT

Chart HBM Healthcare Investments AG

Duration

Period

HBMN: Dynamic Chart

Company Profile

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

Employees

700

Sector

Investment Management & Fund Operators

Calendar

Jan. 22 - Q3 2026 Earnings Release

More about the company